We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,122

CRISPR Update - July 2016
  • Foley & Lardner LLP
  • USA
  • July 29 2016

This is the first update on CRISPR, following on from our June 24 web conference entitled, "Navigating the CRISPR Patent Landscape and Business


AMA Adopts Ethical Guidelines for Telemedicine Providers
  • Foley & Lardner LLP
  • USA
  • July 28 2016

At its annual meeting on June 13, the American Medical Association (AMA) adopted ethical guidelines for the use of telemedicine, affirming the


The Promise And Pitfalls Of 3D Printing
  • Foley & Lardner LLP
  • USA
  • July 27 2016

3D printing offers great promise for innovation and manufacturing, but this tool has expanded the scope of patented products that can be easily and


Hospital Text Messaging Rules Placed on Hold by Joint Commission
  • Foley & Lardner LLP
  • USA
  • July 26 2016

The Joint Commission, which accredits hospitals and other health care organizations, hit pause on its prior May 2016 announcement to allow secure


Report Warns Providers of HIPAA Violations When Responding to Negative Online Reviews
  • Foley & Lardner LLP
  • USA
  • July 25 2016

ProPublica, a public interest investigative newsroom, recently identified more than 3,500 one-star medical reviews on Yelp in which patients


Can FDA Implement The BPCIA As The CAFC Suggested?
  • Foley & Lardner LLP
  • USA
  • July 21 2016

In Amgen v. Apotex, the Federal Circuit held that under the Biologics Price Competition and Innovation Act (“BPCIA”), “an applicant must provide a


Rhode Island’s New Law Requires Health Plans Cover Telemedicine Services
  • Foley & Lardner LLP
  • USA
  • July 19 2016

Rhode Island marks the 31st state to enact a telemedicine commercial reimbursement statute. The Telemedicine Coverage Act (HB 7160B) was signed into


En Banc CAFC Requires UCC Sale For On Sale Bar
  • Foley & Lardner LLP
  • USA
  • July 19 2016

In an en banc decision issued in The Medicines Company v. Hospira, Inc., the Federal Circuit determined that in order for a commercial transaction to


FTC Battles Hospital Mergers: What to Watch for in this Summer’s High-Profile Appeals
  • Foley & Lardner LLP
  • USA
  • July 18 2016

In a town that is no stranger to landmark hospital merger cases, last month a Chicago federal judge denied the Federal Trade Commission's (FTC


IRS Denies Exempt Status for Non-MSSP Accountable Care Organizations
  • Foley & Lardner LLP
  • USA
  • July 14 2016

In April, the IRS released a private letter ruling denying section 501(c)(3) status to an accountable care organization (“ACO”) that contracted with